UHNW AESTHETICS
01 / 10The Linda Evangelista Case
THE LINDA EVANGELISTA CASE
Read the context
Risk and decision points in a non-invasive treatment pathway
01 PUBLICLY REPORTED EVENTS
02 / 10A Timeline of Reported Consequences
7
TREATMENTS
2
CORRECTIVE PROCEDURES CITED
USD 50 million
DAMAGES CLAIMED
02 MEDICAL AND TECHNICAL RISKS
03 / 10“Non-Invasive” Addresses Only One Dimension of Risk
01
VISIBLE PROCEDURAL FEATURES
02
MEDICAL AND TECHNICAL REVIEW
03 PHASE 1 | PROCEDURE KNOWLEDGE
04 / 10Procedure-Specific Foundations Before Individual Review
01
PROCEDURE
02
RISK
03
QUALITY
04 PHASE 2 | DIRECT PHYSICIAN MANDATE
05 / 10Individual Review in a Separate Physician-Patient Relationship
- 1
PHASE 1 CONCLUDES
- 2
PARTICIPANT APPOINTS FREELY
- 3
DIRECT PHYSICIAN MANDATE BEGINS
05 REVIEW POINTS IN THIS CASE
06 / 10Every Subsequent Treatment Is a Separate Decision Point
- 01
BEFORE THE FIRST TREATMENT
- 02
BEFORE EACH FURTHER TREATMENT
- 03
AT THE FIRST UNEXPLAINED FINDING
06 COUNTERFACTUAL ANALYSIS
07 / 10Potential Functions of Independent Oversight
01
INFORMED DECISION
02
SELECTION DUE DILIGENCE
03
REVIEW EACH TREATMENT
07 INDIVIDUAL MANDATE FRAMEWORK
08 / 10Defining an individual physician mandate
A · INDEPENDENT DECISION REVIEW
Individual agreement based on accepted scopeB · COMPLEX OR REVISION DUE DILIGENCE
Agreed in writing before acceptanceC · AGREED CONTINUITY SUPPORT
No public package or price tier08 REVIEW STRUCTURE AND ROLE SEPARATION
09 / 10Information and Individual Medicine Remain Separate
- 01
PROCEDURE INFORMATION, NO PATIENT FILE
- 02
INDIVIDUAL REVIEW IN A DIRECT MANDATE
- 03
AGREED TREATMENT DECISION POINTS
09 SOURCES AND LIMITATIONS
10 / 10Public Sources and Methodological Constraints
11
PUBLIC SOURCES
From case to methodCOMPLETION
Understand decision gates as a governed process.
Repeated procedures and early warning signs show why orientation and individual assessment must remain separate.
Understand the two-phase modelSwipe to continue
Chapter 1 / 10: The Linda Evangelista Case
UHNW AESTHETICS
01 / 10The Linda Evangelista Case
Risks and decision points in a non-invasive treatment pathway
- USD 50 millionCLAIMED IN THE LITIGATION
- No amount was awarded by a court; the settlement amount was not disclosed.1,11
According to her account, the consequences included physical, professional and social effects, with psychological distress continuing through 2025.1,8
KEY REVIEW POINTS
Before selecting the provider and device
Before each further treatment
At the first unexplained finding